Literature DB >> 13896634

Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.

P R GANGADHARAM, A L BHATIA, S RADHAKRISHNA, J B SELKON.   

Abstract

Since isoniazid is metabolized in man to several derivatives with little or no specific activity against the tubercle bacillus, its rate of inactivation in the body may have an important bearing on its efficacy as an antituberculosis drug. The inactivation rate, though constant in any one person, is known to vary from individual to individual and from race to race. A series of studies on the rate of inactivation of isoniazid in Indian patients with pulmonary tuberculosis has recently been undertaken at the Tuberculosis Chemotherapy Centre, Madras. The present paper describes the first of these studies, in which the concentration of isoniazid in the serum of patients admitted to a controlled comparison of four domiciliary chemotherapeutic regimens was determined by microbiological assay four-and-a-half hours after administration of a standard dose of isoniazid (3 mg/kg body-weight). Patients with serum levels of 0.58 mug/ml or more were classified as slow inactivators of isoniazid and those with levels below 0.58 mug/ml as rapid inactivators. By this definition, 195 (61%) of the 321 patients studied were found to be slow inactivators and 126 (39%) rapid inactivators. A relationship was shown between sex and the rate of inactivation, there being a significantly higher proportion of rapid inactivators among the females than among the males. The observed estimates of the error of the microbiological assay procedure are discussed and possible ways of reducing the error suggested.

Entities:  

Keywords:  ISONIAZID/metabolism; TUBERCULOSIS, PULMONARY/therapy

Mesh:

Substances:

Year:  1961        PMID: 13896634      PMCID: PMC2555630     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  20 in total

1.  Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro.

Authors:  M L COHN; G MIDDLEBROOK; W F RUSSELL
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Comparison of isoniazid concentrations in the blood of people of Japanese and European descent; therapeutic and genetic implications.

Authors:  H W HARRIS; R A KNIGHT; M J SELIN
Journal:  Am Rev Tuberc       Date:  1958-12

3.  A critical analysis of the accuracy of a chemical and biologic method of determining serum free isoniazid.

Authors:  S J BERTE; H C LEIFHEIT; H J DEWLETT; E B TUCKER
Journal:  Am Rev Tuberc       Date:  1959-03

4.  Reliability of a microbiologic assay technique for measuring low concentrations of isoniazid.

Authors:  J C BELL; D K RIEMENSNIDER
Journal:  Am Rev Tuberc       Date:  1957-06

5.  Use of a serum microbiologic assay technique for estimating patterns of isoniazid metabolism.

Authors:  J C BELL; D K RIEMENSNIDER
Journal:  Am Rev Tuberc       Date:  1957-06

6.  Clinical implications of isoniazid blood levels in pulmonary tuberculosis.

Authors:  R S MITCHELL; J C BELL
Journal:  N Engl J Med       Date:  1957-11-28       Impact factor: 91.245

7.  Effect of para-aminosalicylic acid on serum isoniazid levels in man.

Authors:  W MANDEL; M L COHN; W F RUSSELL; G MIDDLEBROOK
Journal:  Proc Soc Exp Biol Med       Date:  1956-03

8.  Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients.

Authors:  M L COHN; W MANDEL; G MIDDLEBROOK; W F RUSSELL
Journal:  Am J Med Sci       Date:  1957-01       Impact factor: 2.378

9.  Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds.

Authors:  J BERNSTEIN; W A LOTT; B A STEINBERG; H L YALE
Journal:  Am Rev Tuberc       Date:  1952-04

10.  The estimation of isonicotinic acid hydrazide (nydrazid) in biologic fluids.

Authors:  J M KELLY; R B POET
Journal:  Am Rev Tuberc       Date:  1952-04
View more
  18 in total

1.  Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects.

Authors:  H G Boxenbaum; I Berkersky; V Mattaliano; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.

Authors:  D A MITCHISON
Journal:  Br Med J       Date:  1965-05-22

Review 3.  An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors:  Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

4.  Antituberculous therapy in children.

Authors:  V Seth
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

Review 5.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

6.  Effect of pyridoxine on vitamin B6 concentrations and glutamic-oxaloacetic transaminase activity in whole blood of tuberculous patients receiving high-dosage isoniazid.

Authors:  D V Krishnamurthy; J B Selkon; K Ramachandran; S Devadatta; D A Mitchison; S Radhakrishna; H Stott
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

7.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

8.  Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.

Authors:  A K Karim; M S Elfellah; D A Evans
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

9.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS.

Authors:  P R GANGADHARAM; S DEVADATTA; W FOX; C N NAIR; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

10.  Isoniazid plus thioacetazone compared with two regimens of isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis in South Indian patients.

Authors: 
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.